JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
GANX - Gain Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary GANX Stock
Financials
Financials GANX Stock
Loading...
Loading...
Income Statement
Income Statement GANX Stock
Balance Sheet
Balance Sheet GANX Stock
Cash Flow Statement
Cash Flow Statement GANX Stock
Loading...
Loading...
Home
Stocks
Gain Therapeutics, Inc. (GANX)
Financials
Financials of GANX
Loading...
Loading...
Loading...
Loading...
GANX Financials - Gain Therapeutics Income & Cash Flow | Ledgeburg
Revenue
N/A
Operating Income
$-18.710702M
Net Income
$-20.161099M
Share Count (Basic)
32.968336M
Operating Cash Flow
$-18.465432M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$20.837628M
Total Debt
$400.953K
Annual
Quarterly
Revenue $USD
0
50K
100K
150K
FY2021
FY2022
FY2023
Revenue $USD
No data available
Annual
Quarterly
Net Income $USD
-22M
-20M
-18M
-16M
-14M
Annual
Quarterly
Margins
Gross
Operating
Net
-40000%
-30000%
-20000%
-10000%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-5.5M
-5M
-4.5M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
No data available